We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Novartis Ireland Limited

Vista Building, Elm Park Business Park, Merrion Road, Dublin 4, Ireland
Telephone: +353 1 2601255
Fax: +353 1 2601263
Medical Information e-mail: medinfo.dublin@novartis.com
Patient Information Leaflet last updated on medicines.ie: 13/09/2017
PIL Maxitrol Eye Drops

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 13/09/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 26/05/2017 and displayed until 13/09/2017
Reasons for adding or updating:
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision
Updated on 09/01/2017 and displayed until 26/05/2017
Reasons for adding or updating:
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
Updated on 08/12/2014 and displayed until 09/01/2017
Reasons for adding or updating:
  • Change to side-effects
Updated on 26/06/2014 and displayed until 08/12/2014
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to instructions about missed dose
  • Change to warnings or special precautions for use
Updated on 09/04/2014 and displayed until 26/06/2014
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 21/02/2014 and displayed until 09/04/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 13/01/2014 and displayed until 21/02/2014
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 04/04/2011 and displayed until 13/01/2014
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 12/08/2010 and displayed until 04/04/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL
Updated on 10/09/2004 and displayed until 12/08/2010
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Dexamethasone
   Polymyxin B sulfate
   Neomycin sulfate